NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

CRISPR / Cas9基因組編輯產品市場(2020)

The 2020 Market for CRISPR/Cas9 Genome Editing Products

出版商 BioInformatics Inc. 商品編碼 984832
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
CRISPR / Cas9基因組編輯產品市場(2020) The 2020 Market for CRISPR/Cas9 Genome Editing Products
出版日期: 2020年10月31日內容資訊: 英文 104 Pages
簡介

CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats)是一種簡單而強大的基因組編輯技術。結合Cas9蛋白,該技術可以在從農業生物技術到治療方法的廣泛應用中對人,動物和植物DNA進行特定的改變(添加,修飾,刪除)。

另外,Cas9變體是供應商彼此區分的重要途徑。此外,很可能會開發出多種CRISPR/Cas9系統並正在申請專利,這為供應商擴展CRISPR/Cas9產品提供了方便。結果,基因組編輯市場已經佔據了CRISPR/Cas9的一半以上,預計在未來幾年中將迅速增長。

該報告調查了CRISPR/Cas9基因組編輯產品市場,並提供了有關市場規模和預測,技術,實驗計劃,COVID-19的影響,未來需求,市場上的主要公司等信息。

本報告中列出的公司

  • AddGene
  • Agilent Technologies
  • Allelebiotech
  • ATUM (DNA 2.0)
  • Cellecta, Inc
  • Clontech (Takara)
  • Dharmacon (GE Healthcare Life Sciences)
  • Genecopia
  • GenScript
  • Horizon Discovery
  • IDT (Integrated DNA Technologies)
  • Inscripta
  • Lonza
  • MilliporeSigma
  • New England Biolabs (NEB)
  • Origene
  • Santa Cruz
  • SBI System Biosciences
  • Taconic Biosciences
  • The Jackson Lab
  • Thermo Fisher Scientific
  • Transposagen
  • Twist Bioscience等

目錄

市場分析

  • 基因組編輯工具和技術
  • 市場規模
  • 市場預測
  • 地理突圍

調查數據

COVID-19對CRISPR實驗的影響

使用CRISPR/Cas9進行實驗設計

  • 使用CRISPR/Cas9的研究內容(疾病研究,藥物發現靶標的鑑定和驗證基因治療,工業微生物工程AgBio應用,幹細胞研究,使用模型生物的研究在體外應用中使用CRISPR的治療方法的開發,使用CRISPR的診斷方法,功能基因組學,癌症,發育生物學,細胞係發育)
  • 使用的方法
  • 使用的系統
  • 每月CRISPR實驗的次數

CRISPR/Cas9實驗工具箱

  • RNA文庫來源
  • 編輯和控制目標
  • 用於生成指導RNA的工具
  • 對工具的滿意度
  • 用於生成指導RNA的格式(漿液扳手病毒顆粒,AAV顆粒等)
  • 使用的方法
  • 使用的DNA類型
  • 使用的CRISPR變體(SpCas9,D10a或H840a突變,dCas9,Cpf1□,FnCas9□,Cas13a等)

CRISPR/Cas9實驗的未來需求

  • 改進步驟
  • 供應商意識
  • 推薦品牌的可能性
  • 滿意
  • 滿意的原因
  • 實驗室當前的預算和增長
目錄
Product Code: 20-020

This report provides an in-depth and up-to-date look into scientists' use of the genome editing tool, CRISPR/Cas9. Our survey reveals that while the market is growing steadily, there are challenges confronting suppliers. For instance, Bioinformatics found that over a quarter of scientist respondents said they were highly or somewhat likely to switch away from their primary brand in the near future. That trend represents a threat for some companies, but also an opportunity for others, and the report details what factors drive brand selection and switching behavior. Lab budgets for CRISPR-related research and vendor preferences are also detailed. Based on a survey of scientists utilizing CRISPR/Cas9 in their research, this report provides unique insights on the following:

  • Scientists and Their Changing Toolbox for CRISPR/Cas9 Experiments
  • Applications They Are Using CRISPR/Cas9 For
  • What Brands They Use, What They'd Continue Using
  • What Functions They'd Like to Improve
  • Guide RNA Practices and Preferences
  • Target Per Experiment, Lipid Delivery Methods, Off-Target Effects Detection and Other Trends
  • Their CRISPR-Related Lab Budgets
  • CRISPR Variants and Their Usage
  • Experience Level of Scientists w CRISPR/Cas9
  • The Impact of COVID-19 on CRISPR/Cas9 Studies

The report also provides analyst-modeled market data for CRISPR/Cas9:

  • Market Size
  • Forecast
  • Geographic Breakout
  • Pharma and Biotech Industry Breakout

Clustered Regularly Interspaced Short Palindromic Repeats, or more popularly "CRISPR", is a simple yet powerful genome editing technique. When coupled with the Cas9 protein, the technology allows for specific changes (addition, modification and deletions) to be made to the DNA of humans, animals, and plants, thereby offering a tremendous amount of potential in a wide array of applications ranging from agriculture biotechnology to therapeutics.

Cas9 variants have become an important means by which suppliers differentiate themselves from each other. Furthermore, because of the nascent nature of the technology, numerous variations on the CRISPR/Cas9 system are likely still waiting to be developed and patented, leaving the door open for suppliers to broaden their CRISPR/Cas9 product offerings. Consequently, the genome editing market, of which CRISPR/Cas9 already accounts for more than half, is poised to expand rapidly over the coming years.

Inform Your Marketing Plans with The Opinions of Scientific Customers

Most scientists use multiple suppliers and use CRISPR/Cas9 for a range of applications. This report informs you of where to best target your marketing to properly meet these needs. For companies who produce CRISPR/Cas9 products or provide CRISPR/Cas9 services, this rapidly growing market and fluctuating brand loyalty presents a unique opportunity to win market share by successfully satisfying scientists' needs for effective, quality products and services.

Companies Covered in the Report Include:

  • AddGene
  • Agilent Technologies
  • Allelebiotech
  • ATUM (DNA 2.0)
  • Cellecta, Inc
  • Clontech (Takara)
  • Dharmacon (GE Healthcare Life Sciences)
  • Genecopia
  • GenScript
  • Horizon Discovery
  • IDT (Integrated DNA Technologies)
  • Inscripta
  • Lonza
  • MilliporeSigma
  • New England Biolabs (NEB)
  • Origene
  • Santa Cruz
  • SBI System Biosciences
  • Taconic Biosciences
  • The Jackson Lab
  • Thermo Fisher Scientific
  • Transposagen
  • Twist Bioscience
  • Other

Table of Contents

Market Analysis

  • Genome Editing Tools and Techniques
  • Market Size
  • Market Forecast
  • Geographic Breakout

Survey Data

COVID-19 Impact on CRISPR Experiments

Experimental Design Using CRISPR/Cas9

  • Research Objectives Using CRISPR/Cas9 (Disease research, Drug target identification and validation Gene therapy, Engineering of microbes for industrial uses AgBio applications, Stem cell research, Research using model organisms Development of CRISPR-based therapeutics in vitro applications, Development of CRISPR-based diagnostics, Functional Genomics, Cancer, Developmental Biology, Cell line development)
  • Methods Used
  • Systems Used
  • How many CRISPR experiments/month

Toolbox for CRISPR/Cas9 Experiments

  • Source of RNA Libraries
  • Targets Edited and Controlled
  • Tools Used to Generate Guide RNAs
  • Satisfaction With Tools
  • Formats Used for Generating Guide RNAs (Plasmids Lentivirus particles AAV particles Others)
  • Methods Used
  • Type of DNA Used
  • CRISPR Variants Used (SpCas9, D10a or H840a mutation, dCas9, Cpf1 enzyme, FnCas9 enzyme, Cas13a, Others)

Future Needs for CRISPR/Cas9 Experiments

  • Steps to Improve
  • Awareness of Suppliers
  • Likelihood of Recommending a Brand
  • Satisfaction Level
  • Reasons for Satisfaction
  • Labs Current Budget and Increases